UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
Article in Cancer Medicine (August 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma
Article in Pathology & Oncology Research (January 2023)
VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
Article in Frontiers in Endocrinology (March 2022)